Loading...

Hims & Hers Health, Inc.

HIMSNYSE
Consumer DefensiveHousehold & Personal Products
$56.59
$4.19(8.00%)

Hims & Hers Health, Inc. (HIMS) Stock Overview

Explore Hims & Hers Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
69.33%
69.33%
Profit Growth
$0.74
635.28%
EPS Growth
$0.74
627.27%
Operating Margin
6.16%
310.18%
ROE
35.97%
635.28%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
5
Hold
5
Sell
6
Strong Sell
0

Price Targets

Low$18.00
Average$27.75
High$68.00

Company Profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

CEO

Mr. Andrew Dudum

Employees

1,637

Headquarters

2269 Chestnut Street, San Francisco, CA

Founded

2019

Frequently Asked Questions